Puravankara Ltd approved unaudited standalone and consolidated results for Q3 and 9M ended Dec 31, 2025, re-appointed the MD for five years, approved postal ballot, and sanctioned a merger of two wholly owned subsidiaries. Includes note on partnership entities’ results and related auditors’ reports.